Clinical use of FLT3 inhibitors in acute myeloid leukemia

por Sutamtewagul, Grerk, Vigil, Carlos E
Publicado 2018

Safety and efficacy of azacitidine in myelodysplastic syndromes

por Vigil, Carlos E, Martin-Santos, Taida, Garcia-Manero, Guillermo
Publicado 2010

A prospective biomarker analysis of alvocidib followed by cytarabine and mitoxantrone in MCL-1-dependent relapsed/refractory acute myeloid leukemia

por Zeidner, Joshua F., Lin, Tara L., Vigil, Carlos E., Fine, Gil, Yair Levy, M., Nazha, Aziz, Esteve, Jordi, Lee, Daniel J., Yee, Karen, Dalovisio, Andrew, Wang, Eunice S., Bergua Burgues, Juan M., Schriber, Jeffrey, Litzow, Mark R., Frankfurt, Olga, Castillo, Teresa Bernal Del, Bhatt, Vijaya Raj, Bhatnagar, Bhavana, Mehta, Priyanka, Dillon, Richard, Vicente, Maria Vidriales, Anthony, Stephen, Bearss, David, Montesinos, Pau, Douglas Smith, B.
Publicado 2021